218 related articles for article (PubMed ID: 19416900)
1. Design of anti- and pro-aggregation variants to assess the effects of methionine oxidation in human prion protein.
Wolschner C; Giese A; Kretzschmar HA; Huber R; Moroder L; Budisa N
Proc Natl Acad Sci U S A; 2009 May; 106(19):7756-61. PubMed ID: 19416900
[TBL] [Abstract][Full Text] [Related]
2. Using isotopically-coded hydrogen peroxide as a surface modification reagent for the structural characterization of prion protein aggregates.
Serpa JJ; Makepeace KA; Borchers TH; Wishart DS; Petrotchenko EV; Borchers CH
J Proteomics; 2014 Apr; 100():160-6. PubMed ID: 24316355
[TBL] [Abstract][Full Text] [Related]
3. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
[TBL] [Abstract][Full Text] [Related]
4. Self-assembly of recombinant prion protein of 106 residues.
Baskakov IV; Aagaard C; Mehlhorn I; Wille H; Groth D; Baldwin MA; Prusiner SB; Cohen FE
Biochemistry; 2000 Mar; 39(10):2792-804. PubMed ID: 10704232
[TBL] [Abstract][Full Text] [Related]
5. Methionine sulfoxides on prion protein Helix-3 switch on the alpha-fold destabilization required for conversion.
Colombo G; Meli M; Morra G; Gabizon R; Gasset M
PLoS One; 2009; 4(1):e4296. PubMed ID: 19172188
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of Helix-3 methionines precedes the formation of PK resistant PrP.
Canello T; Frid K; Gabizon R; Lisa S; Friedler A; Moskovitz J; Gasset M; Gabizon R
PLoS Pathog; 2010 Jul; 6(7):e1000977. PubMed ID: 20625387
[TBL] [Abstract][Full Text] [Related]
7. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
8. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
[TBL] [Abstract][Full Text] [Related]
9. Methionine sulfoxides on PrPSc: a prion-specific covalent signature.
Canello T; Engelstein R; Moshel O; Xanthopoulos K; Juanes ME; Langeveld J; Sklaviadis T; Gasset M; Gabizon R
Biochemistry; 2008 Aug; 47(34):8866-73. PubMed ID: 18680312
[TBL] [Abstract][Full Text] [Related]
10. Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics.
Viles JH; Donne D; Kroon G; Prusiner SB; Cohen FE; Dyson HJ; Wright PE
Biochemistry; 2001 Mar; 40(9):2743-53. PubMed ID: 11258885
[TBL] [Abstract][Full Text] [Related]
11. Effects of pH and aggregation in the human prion conversion into scrapie form: a study using molecular dynamics with excited normal modes.
Lima AN; de Oliveira RJ; Braz ASK; de Souza Costa MG; Perahia D; Scott LPB
Eur Biophys J; 2018 Jul; 47(5):583-590. PubMed ID: 29546436
[TBL] [Abstract][Full Text] [Related]
12. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous conformational change within the prion protein--implications for disease pathogenesis?
Jackson GS
Bioessays; 2001 Sep; 23(9):772-4. PubMed ID: 11536289
[TBL] [Abstract][Full Text] [Related]
14. Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.
Elmallah MI; Borgmeyer U; Betzel C; Redecke L
Prion; 2013; 7(5):404-11. PubMed ID: 24121542
[TBL] [Abstract][Full Text] [Related]
15. Mapping the antigenicity of copper-treated cellular prion protein with the scrapie isoform.
Wong BS; Li R; Sassoon J; Kang SC; Liu T; Pan T; Greenspan NS; Wisniewski T; Brown DR; Sy MS
Cell Mol Life Sci; 2003 Jun; 60(6):1224-34. PubMed ID: 12861388
[TBL] [Abstract][Full Text] [Related]
16. Methionine oxidation within the prion protein.
Bettinger J; Ghaemmaghami S
Prion; 2020 Dec; 14(1):193-205. PubMed ID: 32744136
[TBL] [Abstract][Full Text] [Related]
17. Conversion efficiency of bank vole prion protein in vitro is determined by residues 155 and 170, but does not correlate with the high susceptibility of bank voles to sheep scrapie in vivo.
Piening N; Nonno R; Di Bari M; Walter S; Windl O; Agrimi U; Kretzschmar HA; Bertsch U
J Biol Chem; 2006 Apr; 281(14):9373-84. PubMed ID: 16455657
[TBL] [Abstract][Full Text] [Related]
18. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
19. Disassociation of β1-α1-β2 from the α2-α3 domain of prion protein (PrP) is a prerequisite for the conformational conversion of PrP
Chandrasekaran P; Santosh Kumar C; Rangachari K; Sekar K
Int J Biol Macromol; 2019 Sep; 136():368-376. PubMed ID: 31207327
[TBL] [Abstract][Full Text] [Related]
20. The hypothesis of the catalytic action of nucleic acid on the conversion of prion protein.
Cordeiro Y; Silva JL
Protein Pept Lett; 2005 Apr; 12(3):251-5. PubMed ID: 15777274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
